At this time, posts about Cellmat Therapeutics are rapidly increasing on portals and stock communities, while foreign investors are tentatively recorded to have net sold 15,000 shares today. Cellmat Therapeutics is known as a company distributing gift certificate discounts and dental materials.


As of 12:30 PM on the 24th, Cellmat Therapeutics' stock price is 6,900 KRW, up 4.86% from the previous day, with a trading volume of 3,476,565 shares, which is 75.31% of the 5-day average trading volume. On December 15th, Cellmat Therapeutics became a market issue with the headline "Surge due to news of a mutant coronavirus."


In addition to Cellmat Therapeutics, posts by investors are also rapidly increasing for LIS (138690), Seoul Food (004410), and SNK (950180).



※ Source: AI Investment Assistant AI Rassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing